151 related articles for article (PubMed ID: 2937870)
1. Galactorrhea in DMPA users: incidence and clinical significance.
Gongsakdi D; Rojanasakul A
J Med Assoc Thai; 1986 Jan; 69(1):28-32. PubMed ID: 2937870
[TBL] [Abstract][Full Text] [Related]
2. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
3. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
Polaneczky M; Guarnaccia M; Alon J; Wiley J
Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283
[TBL] [Abstract][Full Text] [Related]
4. Effects of the injectable contraceptive depot medroxyprogesterone acetate in Thai women with liver fluke infestation: final results.
Grossman RA; Asawasena W; Chalpati S; Taewtong D; Tovanabutra S
Bull World Health Organ; 1979; 57(5):829-37. PubMed ID: 161523
[TBL] [Abstract][Full Text] [Related]
5. A case-control study of breast cancer and hormonal contraception in Costa Rica.
Lee NC; Rosero-Bixby L; Oberle MW; Grimaldo C; Whatley AS; Rovira EZ
J Natl Cancer Inst; 1987 Dec; 79(6):1247-54. PubMed ID: 2961909
[TBL] [Abstract][Full Text] [Related]
6. The pituitary reserve for gonadotrophins and prolactin in women under long-term use of depo-medroxyprogesterone acetate (DMPA) as a contraceptive.
Mukasa FR; Sekadde-kigondu CB; Mati JK; Njoroge JK
J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):160-3. PubMed ID: 12313677
[TBL] [Abstract][Full Text] [Related]
7. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
Kaunitz AM
J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
[TBL] [Abstract][Full Text] [Related]
8. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception.
Nelson AL
J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer and depot-medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Thomas DB; Noonan L; Whitehead A
Bull World Health Organ; 1985; 63(3):513-9. PubMed ID: 2931206
[TBL] [Abstract][Full Text] [Related]
10. Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.
Westhoff C
J Reprod Med; 1996 May; 41(5 Suppl):401-6. PubMed ID: 8725702
[TBL] [Abstract][Full Text] [Related]
11. Continuation of injectable contraceptives in Thailand.
Narkavonnakit T; Bennett T; Balakrishnan TR
Stud Fam Plann; 1982 Apr; 13(4):99-105. PubMed ID: 6216633
[TBL] [Abstract][Full Text] [Related]
12. Galactorrhea and hyperprolactinemia during treatment of polycystic ovary syndrome.
Wortsman J; Hirschowitz JS
Obstet Gynecol; 1980 Apr; 55(4):460-3. PubMed ID: 6768040
[TBL] [Abstract][Full Text] [Related]
13. Galactorrhea in oral contraceptive users.
Holtz G
J Reprod Med; 1982 Apr; 27(4):210-2. PubMed ID: 7201522
[TBL] [Abstract][Full Text] [Related]
14. Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users.
Sereepapong W; Chotnopparatpattara P; Taneepanichskul S; Markham R; Russell P; Fraser IS
Hum Reprod; 2004 Mar; 19(3):547-52. PubMed ID: 14998949
[TBL] [Abstract][Full Text] [Related]
15. Depot medroxyprogesterone acetate contraception in women with medical problems.
Frederiksen MC
J Reprod Med; 1996 May; 41(5 Suppl):414-8. PubMed ID: 8725704
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of injectable contraceptive users in a low-income population in Texas.
Sangi-Haghpeykar H; Poindexter AN; Moseley DC; Bateman L; Reid ED
Fam Plann Perspect; 1995; 27(5):208-11, 225. PubMed ID: 9104608
[TBL] [Abstract][Full Text] [Related]
17. Forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
Sanches L; Marchi NM; Castro S; Juliato CT; Villarroel M; Bahamondes L
Contraception; 2008 Nov; 78(5):365-9. PubMed ID: 18929732
[TBL] [Abstract][Full Text] [Related]
18. Medroxyprogesterone acetate as an injectable contraceptive.
Heber KR
Aust Fam Physician; 1988 Mar; 17(3):199-201, 204. PubMed ID: 2965570
[TBL] [Abstract][Full Text] [Related]
19. [Injectable contraceptive, DMPA, serum HDL cholesterol and heart infarct].
Kremer J; de Bruijn HW; Hindriks FR
Ned Tijdschr Geneeskd; 1981 Aug; 125(35):1418-21. PubMed ID: 6456421
[TBL] [Abstract][Full Text] [Related]
20. [Acceptability of medroxyprogesterone acetate among medical and paramedical personnel in family planning].
Cervantes A; Velasco Murillo V; Campos Cordero J; Correu Azcona S
Ginecol Obstet Mex; 1982 Apr; 50(300):85-8. PubMed ID: 6222944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
